Skip to content
NYSE: IGC | Borse Berlin: IGS1.BE | Frankfurt: IGS1
IGC

IGC

India Globalization Capital Inc.

  • Home
  • IGC Pharma
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance

IGC Form 10-Q

February 12, 2019September 10, 2019 by charlie

Posted in News and Filings, SEC Filings

Post navigation

← IGC Announces Financial Results for Quarter Ended December 31, 2018
IGC Announces Extension of Expiration Date and Reduction of Exercise Price of its Publicly Traded Warrants →

Site Map

  • Home
  • IGC Pharma
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance

Contact

India Globalization Capital
Potomac, MD, United States

info@igcinc.us
301-983-0998